[
    [
        {
            "time": "2020-12-16",
            "original_text": "U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs 'disappointing'",
            "features": {
                "keywords": [
                    "hospital",
                    "demand",
                    "Lilly",
                    "Regeneron",
                    "COVID-19",
                    "antibody",
                    "drugs",
                    "disappointing"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs 'disappointing'",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2020-12-16",
            "original_text": "SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Prevail Therapeutics Inc. Buyout",
            "features": {
                "keywords": [
                    "SHAREHOLDER",
                    "ALERT",
                    "Rigrodsky",
                    "Long",
                    "Prevail",
                    "Therapeutics",
                    "Investigation",
                    "Buyout"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Prevail Therapeutics Inc. Buyout",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-12-16",
            "original_text": "Top Analyst Reports for Mastercard, Eli Lilly & Citigroup",
            "features": {
                "keywords": [
                    "Analyst",
                    "Reports",
                    "Mastercard",
                    "Eli",
                    "Lilly",
                    "Citigroup"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Top Analyst Reports for Mastercard, Eli Lilly & Citigroup",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-12-16",
            "original_text": "PREVAIL THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRVL and Encourages Investors to Contact the Firm",
            "features": {
                "keywords": [
                    "PREVAIL",
                    "THERAPEUTICS",
                    "Bragar",
                    "Eagel",
                    "Squire",
                    "Sale",
                    "PRVL",
                    "Investors"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "PREVAIL THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRVL and Encourages Investors to Contact the Firm",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-12-16",
            "original_text": "Lilly (LLY) to Acquire Prevail Therapeutics for Gene Therapies",
            "features": {
                "keywords": [
                    "Lilly",
                    "Acquire",
                    "Prevail",
                    "Therapeutics",
                    "Gene",
                    "Therapies"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly (LLY) to Acquire Prevail Therapeutics for Gene Therapies",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-12-16",
            "original_text": "Company News for Dec 16, 2020",
            "features": {
                "keywords": [
                    "Company",
                    "News",
                    "Dec",
                    "16",
                    "2020"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Company News for Dec 16, 2020",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 2
            }
        },
        {
            "time": "2020-12-16",
            "original_text": "Lilly (LLY) Stock Up on Raised 2020 View, Upbeat 2021 Guidance",
            "features": {
                "keywords": [
                    "Lilly",
                    "Stock",
                    "Up",
                    "Raised",
                    "2020",
                    "View",
                    "Upbeat",
                    "2021",
                    "Guidance"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly (LLY) Stock Up on Raised 2020 View, Upbeat 2021 Guidance",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]